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BACTERIAL INFECTIONS IN THE URINARY TRACT 
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Urinary tract infections (UTIs) are usually caused by bacterial organisms; however 
fungi and viruses may also infect the urinary tract (1). Bacterial UTI is said to occur in 
about 14% of all dogs at some time during their life (2). In cats the prevalence has 
not been defined but has been estimated in the range of 0.1 to 1% and at least 10 
times less than the estimated prevalence in dogs (3). It was reported that 1% of cats 
admitted to veterinary teaching hospitals were diagnosed with UTI. Infection can 
occur either in the upper or the lower urinary tract or in both sites at once. It might 
sometimes be difficult to detect the location of an infection. Furthermore an infection 
in one part of the urinary tract increases the likelihood of another part of the urinary 
tract becoming infected as well (1). Most UTIs are the result of ascending migration 
of pathogens from the distal urogenital tract to the sterile part. UTI develops when the 
host’s defenses are overwhelmed by microbes. Normal defenses include normal 
micturation, anatomic properties (e.g. urethral peristalsis), mucosal defense barrier 
(e.g. glycosaminoglycan layer), antimicrobial properties of urine (e.g. extreme pH), 
and systemic immunocompetence.  
 
UTI is usually caused by one single bacterial species (1). Predominant bacterial 
species are E. coli, followed by gram-positive cocci (Staphylococcus spp., 
Streptococcus spp., Enterococcus spp.).  
 
Typical clinical signs of lower UTI are stranguria, pollakiuria, and hematuria. 
Infections of the upper urinary tract may cause abdominal pain or clinical signs 
caused by septicemia or renal failure (1). Asymptomatic bacteriuria or asymptomatic 
UTI in human beings is defined by a specified quantitative count of bacteria in a urine 
specimen from a person without symptoms or signs relating to UTI (4). Asymptomatic 
bacteriuria is also common in animals and it is difficult to localize it in either the upper 
or the lower urinary tract (1). It is often seen in animals with compromised host 
defense, such as those with glucocorticoid excess or diabetes mellitus.  
 
The gold standard for diagnosis of UTI is urine culture. Examination of the urine 
sediment provides some help in the identification of UTI. More than 4 white blood 
cells per 400X field in unstained sediment under a cover slip together with bacteria 
identified during the same examination are indicatives. However the presence of 
pyuria represents any inflammation and is not synonymous with UTI. The absence of 
pyuria does not rule out UTI. The presence of bacteria might represent contamination 
or amorphous particles resembling bacteria. Cystocentesis is the preferred method of 
urine collection for culture, because lower genitourinary tract contamination is 
avoided (1).  
 
Administration of antimicrobial agents should be based on susceptibility testing. 
Fortunately most antimicrobials are present in urine in high concentrations as a result 
of renal excretion. Which means even if an antibiotic is used to which the organism is 
reported to be resistant a good result may be obtained in an animal that can 
concentrate the urine. An antimicrobial is said to be effective if the urine 
concentration reaches four times the minimum inhibitory concentration (MIC). 
Empirical treatment is often necessary before culture and sensitivity results are 
available. It is recommended to start antibiotic therapy in uncomplicated urinary tract 
infections with amoxicillin or trimethoprim-sulfonamide (5). However local resistance 
patterns might influence the choice. If results of culture and sensitivity testing indicate 
in vitro resistance of the bacterial isolate against the chosen antimicrobial agent 
therapy can be switched to an appropriate antimicrobial agent; however if clinical 
signs resolved, the chosen antimicrobial can be maintained. Not much is known 
about the appropriate duration of treatment but seven days were considered 
reasonable in absence of evidence. In most instances asymptomatic bacteriuria 
should not be treated (5). Complicated UTIs are UTIs of animals with anatomic or 
functional urinary tract anomalies or identifiable predispositions for recurrent or 
persistent UTIs (e.g. diabetes mellitus, renal failure). In these animals treatment for a 
longer period than the routine 7 days may be indicated (up to 4 weeks). In these 
cases it may also be indicated to test the urine after the first week of treatment to 
evaluate the response to therapy, and after the end of treatment to make sure that no 
more bacteria are present. Treatment of UTI is usually successful and nearly 75% of 
infections remain single episodes (3). Recurrent UTIs (three or more episodes within 12 
months) might either be caused by the same organism which was isolated before treatment 
(relapse) or by a different organism (reinfection). In both cases further work up is required to 
identify the underlying causes. If predisposing disorders are not addressed, control of UTI will 
be poor. Reasons for poor response to therapy might be treatment of a non infectious 
problem with antibiotics, infectivity of the antibiotics because of inadequate delivery (poor 
client compliance, poor patient acceptance, ineffective drug or impaired drug transport), 
resistant microbes or super infection with another organism.  
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